← Back
Data updated: Jul 17, 2026
WRASER PHARMS LLC
Generics Pharmaceuticals
WRASER PHARMS LLC is a generic drug manufacturer with 1 FDA-approved products.
2007
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
WRASER PHARMS LLC's Key Drugs
WRASER PHARMS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
WRASER PHARMS LLC's Recent FDA Approvals
New NDA/BLA approvals for WRASER PHARMS LLC over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
WRASER PHARMS LLC's Therapeutic Areas
Disease areas where WRASER PHARMS LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
WRASER PHARMS LLC Pipeline Snapshot
Active clinical trials for WRASER PHARMS LLC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2007-04-03
- Latest
- 2008-11-24
- Applications
- 1